Stockscreener 앱 받기
193.57
1.71%
-3.37
시장 영업 전:
195.21
1.64
+0.85%
Resmed Inc 주식(RMD)의 최신 뉴스
ResMed Inc. $RMD Shares Bought by Deutsche Bank AG - MarketBeat
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
Do experts rate BHP, Cochlear, and ResMed shares as buys, holds, or sells? - The Motley Fool Australia
ResMed CEO Farrell Exercises Options and Sells Shares Under 10b5-1 Plan - TipRanks
Buy, hold, sell: Resmed, Goodman Group, Westpac shares - The Motley Fool Australia
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
ResMed chairman & CEO Michael Farrell sells $968k in stock By Investing.com - Investing.com Australia
Should you continue to hold Resmed stock in your portfolio? - MSN
ResMed chairman & CEO Michael Farrell sells $968k in stock - Investing.com Nigeria
ResMed Inc. stock (US7611521078): Sleep apnea specialist in focus after recent earnings update - AD HOC NEWS
ResMed (NYSE:RMD) CEO Sells $968,054.36 in Stock - MarketBeat
Resmed Insider Sold Shares Worth $968,064, According to a Recent SEC Filing - marketscreener.com
ResMed (NYSE: RMD) CEO sells 4,991 shares after option exercise - Stock Titan
Why ResMed Inc (RMD) Is Set to Outperform the Market: Insights i - GuruFocus
Is This the Right Time to Retain Resmed Stock in Your Portfolio? - TradingView
LGT Capital Partners LTD. Sells 25,752 Shares of ResMed Inc. $RMD - MarketBeat
BLI Banque de Luxembourg Investments Cuts Stake in ResMed Inc. $RMD - MarketBeat
Down 28% in a year, should I buy the dip on Resmed shares right now? - The Motley Fool Australia
Do Wall Street analysts like ResMed stock? - MSN
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
ResMed stock (US7611521078): Revenue growth and sleep-apnea demand stay in focus - AD HOC NEWS
Michael Farrell sells 4,991 RMD shares (NYSE: RMD) via option exercise - Stock Titan
TD Asset Management Inc Has $20.63 Million Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by Los Angeles Capital Management LLC - MarketBeat
PBU The Pension Fund of Early Childhood & Youth Educators Makes New $7.93 Million Investment in ResMed Inc. $RMD - MarketBeat
Goldman Sachs Group Inc. Has $235.83 Million Stock Position in ResMed Inc. $RMD - MarketBeat
Cibc World Market Inc. Sells 8,768 Shares of ResMed Inc. $RMD - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Reduces Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed (RMD) Valuation Check After Q3 FY2026 Results And Sleep Apnea Demand Update - Sahm
Prudential PLC Raises Position in ResMed Inc. $RMD - MarketBeat
Can ResMed's Sleep Apnea Growth Justify Current Valuation Views? - Kalkine Media
CIBC Asset Management Inc Boosts Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
ResMed (RMD) Acquires Noctrix Health to Expand Sleep Disorder Portfolio - Insider Monkey
ResMed Inc. $RMD Shares Sold by Marietta Investment Partners LLC - MarketBeat
Top ResMed (RMD) Competitors 2026 - MarketBeat
ResMed (ASX:RMD) Analysis: What’s Driving Investor Sentiment? - Kalkine
Ord Minnett Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) - The Globe and Mail
A Look at ResMed Inc (RMD) After 4.2% Gain -- GF Value $271.26 v - GuruFocus
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
BofA Securities Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $320 - Moomoo
ResMed completes $340m Noctrix Health acquisition - Yahoo Finance
Is ResMed a Better Buy Than Medtronic? - Trefis
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
ResMed, Inc. Hits 52-Week Low at USD 180.41 Amid Market Struggles - Markets Mojo
ResMed Inc. stock (US7611521078): RMD edges higher as institutional investors add exposure - AD HOC NEWS
ResMed (NYSE: RMD) counsel surrenders shares for RSU tax withholding - Stock Titan
Are CSL and ResMed shares buys at 52-week lows? - MSN
Is Market Sentiment Turning Positive for ResMed (ASX:RMD) Stock? - Kalkine
US: Resmed expands clinical sleep health portfolio with completion of Noctrix Health acquisition - Investors in Healthcare
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide? - Yahoo Finance
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million - Benzinga
Westpac Banking Corp Has $5.43 Million Position in ResMed Inc. $RMD - MarketBeat
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million - Yahoo Finance
William Blair Maintains ResMed(RMD.US) With Buy Rating - Moomoo
Resmed tackles restless legs syndrome with Noctrix Health takeover - Mugglehead Investment Magazine
Norges Bank Makes New Investment in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Acquired by Bank of New York Mellon Corp - MarketBeat
ResMed Inc. stock falls Friday, underperforms market - MSN
Could Cash Machine ResMed Stock Be Your Next Buy? - Trefis
Transcript : ResMed Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 04 - marketscreener.com
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Air Voel Strengthens CPAP Repair Support for ResMed PAP Device Users in Canada - Scott Coop
RMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Resmed completes $340M Noctrix takeover - MedTech Dive
Resmed completes Noctrix Health acquisition - Medical Buyer
ResMed Stock Delivers Strong Cash Yield – Upside Ahead? - Trefis
ResMed Inc. $RMD Shares Bought by BNP Paribas Financial Markets - MarketBeat
1.47%
2.64%
자본화:
|
볼륨(24시간):